
Where Science Meets Strategy. And Strategy Serves Purpose.
An exclusive forum for senior decision-makers navigating the future of therapeutic innovation.
Snapshot Featured Attendees:
AB Science
Almirall, S.A
Amgen
Arvinas
Astex Pharmaceuticals
AstraZeneca
Bayer
Bicycle Therapeutics
Boehringer Ingelheim
Bristol Myers Squibb
Byondis
Carbon Logic Biotech
Centogene
Centre for Drug Design and Discovery (CD3)
Charles River Laboratories
Charm Therapeutics
Confo Therapeutics
Crescendo Biologics
Eisai
EMBL-EBI
Evox Therapeutics
Fierce Unicorn
Fisher Friedman IP Group
Freie Universitat Berlin
Galapagos NV
Genmab
Genome Biologics
Gilead Sciences
GlaxoSmithKline
Goethe-Universitat Hospital
Heath Innovation Research
Hubrecht Organoid Technology
IRCCS San Raffaele
Janssen (Johnson & Johnson)
Laudea Research GmbH
Leibniz Institute for Farm Animal Biology
Leibniz Institute for Molecular Pharmacology
Leiden University
LEO Pharma
Lhasa Limited
Lonza
Lygature
Max Delbruck Center
Max Planck Institute
Medibiofarma S.L.
Merck Group
Merck Sharp & Dohme (MSD)
Neurocrine Biosciences
Novartis
Parkinson's UK
Pfizer
Pharmablock
Radboud University Nijmegen
Roche
Sosei Heptares
Storm Therapeutics
Symeres
Technische Universitat Berlin
Tehran Polytechnic
TroplQ Health Sciences
Univercity Medicine Berlin
University of Groningen
University of Jerusalem
Vertex Pharmaceuticals

Jens Vogel
Former Global SVP Biologics at Bayer
It's always in the diary! Great program, experience and connections"

Uwe Gottschalk, Keensight Capital, former CSO at Lonza
A clear 10 because of the fantastic combination of different topics and I keep saying, we need inspiration from other industries and the co-location is perfect in that regard.”

Laura Matz, CSO & CTO at Merck KGaA
“A 10. I really enjoyed the conference and meeting so many brilliant minds that are working in this space. I think the future is bright!”

Jesse McCool
CSO, Bionova Scientific
I’ve been going to this event for a long time, it’s a mixture of all different sectors and for the most part you can see all of them in one room You don’t have to make decisions to miss a talk here and there. You see a lot. Its a smaller meeting so it gives you more chances to bump into people and share some ideas
Previous DDIF Attendees Include:
AB Science
Almirall, S.A
Amgen
Angelini
Arvinas
Astex Pharmaceuticals
AstraZeneca
Bayer
Bicycle Therapeutics
Boehringer Ingelheim
Bristol Myers Squibb
Byondis
Carbon Logic Biotech
Centogene
Centre for Drug Design and Discovery (CD3)
Charles River Laboratories
Charm Therapeutics
Confo Therapeutics
Crescendo Biologics
Eisai
EMBL-EBI
Evox Therapeutics
Fierce Unicorn
Fisher Friedman IP Group
Freie Universitat Berlin
Galapagos NV
Genmab
Genome Biologics
Gilead Sciences
GlaxoSmithKline
Goethe-Universitat Hospital
Heath Innovation Research Alliance
Hubrecht Organoid Technology
IRCCS San Raffaele
Janssen (Johnson & Johnson)
Laudea Research GmbH
Leibniz Institute for Farm Animal Biology
Leibniz Institute for Molecular Pharmacology (FMP)
Leiden University
LEO Pharma
Lhasa Limited
Lonza
Lygature
Max Delbruck Center
Max Planck Institute
Medibiofarma S.L.
Merck Group
Merck Sharp & Dohme (MSD)
Neurocrine Biosciences
Novartis
Parkinson's UK
Pfizer
Pharmablock
Radboud University Nijmegen
Roche
Sosei Heptares
Storm Therapeutics
Symeres
Technische Universitat Berlin
Tehran Polytechnic
TroplQ Health Sciences
Univercity Medicine Berlin
University of Groningen
University of Jerusalem
Vertex Pharmaceuticals
-
CSOs, CTOs, Heads of R&D
-
VPs/Directors of Drug Discovery,
-
Director / Head of High-Throughput Screening (HTS)
-
Director of Translational Biology / Cell Biology
-
Head of Computational Biology / AI in Drug Discovery
-
Procurement and Business Development
-
Innovation/Strategy Units
-
Pharmaceutical
-
Biotech Companies
-
Academic & Research Institutions
-
Contract Research Organisations (CROs)
-
Government & Public Health Agencies
-
Investors & Tech Scouts
Building Connections
Discover what C-suite executives, scientists, and innovators are saying about our summits — impromptu interviews and first-hand experiences from leaders driving the future of drug discovery and beyond.
Private Data Protection Disclaimer At GBX Events we are committed to safeguarding the privacy and confidentiality of all our attendees, especially given the seniority and strategic roles of participants at this event. To protect the integrity of our community and the personal data of C-suite executives and senior decision-makers, we do not publicly publish attendee lists. This ensures that your information remains secure, and that you are not subject to unsolicited outreach or misuse of your professional identity. All attendee information is handled with the highest level of discretion and is used solely for essential event-related communications, personalized scheduling, and secure on-site logistics. Data is processed in full compliance with applicable privacy regulations, including the GDPR. By joining our event, you’re entering a trusted environment built on confidentiality, mutual respect, and purposeful connection. For more information, please contact - hello@gbx-events.com